Associations between type of product and inhibitors in previously untreated patients (PUPs) with severe hemophilia: switches and particular products can disturb analysis.
Calvez
Thierry
T
Laurian
Yves
Y
Goudemand
Jenny
J
D000818:Animals; D017951:Antigen Presentation / Q000187:drug effects; D019774:Blood Coagulation Factor Inhibitors / Q000032:analysis* / Q000276:immunology; D015331:Cohort Studies; D003713:Dendritic Cells / Q000276:immunology; D005169:Factor VIII / Q000008:administration & dosage / Q000032:analysis* / Q000276:immunology; D006467:Hemophilia A / Q000097:blood* / Q000188:drug therapy* / Q000276:immunology / Q000401:mortality; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D014841:von Willebrand Factor / Q000032:analysis* / Q000276:immunology
D019774:Blood Coagulation Factor Inhibitors; D014841:von Willebrand Factor; C078147:F8 protein, human; D005169:Factor VIII